葡萄糖摄入量降低了酒精使用障碍患者的渴望,这取决于胰岛素反应
Lea Wetzel1,2,3, Sabine Hoffmann2,4, Iris Reinhard4
1Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.
European addiction research
|July 6, 2025
概括
葡萄糖可能会降低饮酒障碍 (AUD) 患者的酒精渴望,这些人具有正常的胰岛素反应. 这种效应取决于个体的胰岛素反应类型,突出显示了潜在的新治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 内分泌学 在内分泌学.
- 精神病学是一个精神病学.
背景情况:
- 胰岛素是一种调节食欲的激素,与酒精使用障碍 (AUD) 中的酒精渴望有关.
- 增加的胰岛素水平与减少的急性酒精渴望相关.
- 在AUD渴望减少中的个人胰岛素反应动态仍未得到充分研究.
研究的目的:
- 为了研究葡萄糖的管理作为一种急性治疗,以减少AUD患者的酒精渴望.
- 为了检查个人胰岛素反应型对葡萄糖诱导的渴望减少的影响.
主要方法:
- 一项随机,安慰剂控制,双盲交叉研究,涉及80名AUD患者.
- 在8个时间点对渴望和胰岛素水平的评估,包括酒精前后暴露.
- 使用线性混合模型进行分析,考虑快速,正常和缓慢的胰岛素反应型.
主要成果:
- 观察到葡萄糖治疗和胰岛素反应型之间对渴望的显著相互作用.
- 与安慰剂相比,正常胰岛素反应者显示,与安慰剂相比,对葡萄糖的渴望减少了 (p=0.003).
- 快速胰岛素反应者表现出与安慰剂相比增加了对葡萄糖的渴望 (p=0.011);缓慢反应者没有显著差异.
结论:
- 摄入葡萄糖可以有效地减少正常胰岛素反应的AUD患者的酒精渴望.
- 个别的胰岛素反应型显著调节葡萄糖对渴望的影响.
- 需要进行进一步的研究,以探索AUD治疗中葡萄糖介导的渴望减少中的胰岛素反应动态.
相关概念视频
01:16Hormones Regulating Blood Glucose
4.1K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
4.1K
01:15Hypoglycemia and Glucagon
349
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
349
01:02Glucose Homeostasis: Regulation of Blood Glucose
2.6K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
2.6K
01:16Insulin: Dosing Regimen and Adverse Effects
265
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
265
01:24Glucagon-like Receptor Agonists
431
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
431
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
309
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
309